Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 14, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 18, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001762951-26-000006
Filed / recorded
Aug 18, 2026, 9:00 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AbbVie Inc.
Issuer CIK
1551152
Ticker
ABBV
Reporting person
Nicholas Donoghoe
Relationship
Officer
Officer title
EVP, CHIEF BUS/STRAT OFFICER
Security
Option (Right to buy)
Table
Derivative (Table II)
Transaction date
Aug 14, 2026
Transaction code
M
Shares / units
32,710
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 10,904 on February 21, 2020, 10,903 on February 21, 2021, and 10,903 on February 21, 2022.